White Paper

5 ADC Manufacturing Challenges You Need To Know

Source: Ajinomoto Bio-Pharma Services
5 ADC Manufacturing Challenges You Need To Know

The unique targeting capabilities and encouraging clinical trial results of antibody drug conjugates (ADCs) have made them an exciting and promising treatment in the fight against cancer. According to recent analysis, experts anticipate the ADC market to be worth $10 billion annually by 2025. Drug makers face a number of challenges in the manufacturing process for ADCs. Here we provide you with five key areas where pharmaceutical manufacturers may face the biggest uphill battles.

Ajinomoto Bio-Pharma Services